CELLTRION’S COVID-19 ANTIBODY TREATMENT CONFIRMED TO NEUTRALIZE VIRUS VARIANT

Highlights –

• Celltrion’s COVID-19 antibody treatment confirmed to neutralize virus variant.
• The company’s CT-P59, an anti-COVID-19 monoclonal antibody treatment neutralized the British virus variant.
• The company has also tested the same on previously identified six genome mutations.
• The company will conduct a 2nd-phase trial of the antibody cocktail with CT-P....
  Click here to read more

  ---

  Tags : SOUTH KOREA COVID-19 TREATMENT, SOUTH KOREA PHARMACEUTICAL COMPANY, CELLTRION INC., CT-P59 TREATMENT, BRITAIN COVID-19 VARIANT, SOUTH KOREA COVID-19 VARIANT,

  ---

  SHARE THIS ARTICLE